Impact of light chain isotype on clinical features and outcomes in systemic AL amyloidosis

Hopson, M. B., Bhutani, D., Sarkaria, S., Maurer, M. S., Griffin, J. M., Mapara, M., Lentzsch, S., & Chakraborty, R. (2022). Impact of light chain isotype on clinical features and outcomes in systemic AL amyloidosis. Leukemia & Lymphoma, 63(9), 2109–2113. https://doi.org/10.1080/10428194.2022.2060502
Authors:
Madeleine B Hopson
Divaya Bhutani
Shawn Sarkaria
Mathew S Maurer
Jan M Griffin
Markus Mapara
Suzanne Lentzsch
Rajshekhar Chakraborty
Affiliated Authors:
Madeleine B Hopson
Divaya Bhutani
Shawn Sarkaria
Mathew S Maurer
Jan M Griffin
Markus Mapara
Suzanne Lentzsch
Rajshekhar Chakraborty
Columbia Affiliation:
Subjects:
Immunoglobulin Light-chain Amyloidosis (MeSH)
Author Keywords:
al amyloidosis
kappa light chain
lambda light chain
overall survival
organ involvement
elink
Publication Type:
Article
Unique ID:
10.1080/10428194.2022.2060502
PMID:
35465769
DOI:
10.1080/10428194.2022.2060502
Journal:
Leukemia and Lymphoma
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Web of Science Record

Record Created: